Publication | Closed Access
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
233
Citations
67
References
2018
Year
Breast OncologyMedicineAcquired Her2 MutationsCancer BiologyBreast CancerReceptor–directed TherapiesCell BiologyCancer GeneticsSystems BiologyOncologyRadiation OncologyEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1